Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Price

Showing results (101-110 of 500) with videos related to

Pageof 50
Sort By:
Plos One|February 4, 2012
Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activityNatalija Budimir, Anke Huckriede, Tjarko Meijerhof, et al.
Hormone Research|January 18, 2007
Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short statureMichael B Ranke, Anders Lindberg, David A Price, et al.
Journal of Virology|July 1, 2006
Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivoJason M Brenchley, Laura E Ruff, Joseph P Casazza, et al.
Immunology|January 8, 2009
Tricks with tetramers: how to get the most from multimeric peptide-MHCLinda Wooldridge, Anna Lissina, David K Cole, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2006
Overcoming HERG affinity in the discovery of the CCR5 antagonist maravirocDavid A Price, Duncan Armour, Marcel de Groot, et al.
Current Topics in Medicinal Chemistry|September 11, 2008
Overcoming hERG affinity in the discovery of maraviroc; a CCR5 antagonist for the treatment of HIVDavid A Price, Duncan Armour, Marcel de Groot, et al.
Hormone Research|September 5, 2003
The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiencyEdward O Reiter, Anders Lindberg, Michael B Ranke, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)Michael B Ranke, Anders Lindberg, Christopher T Cowell, et al.
Journal of Leukocyte Biology|September 30, 2008
The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expressionPratip K Chattopadhyay, Michael R Betts, David A Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2006
Sharing of T cell receptors in antigen-specific responses is driven by convergent recombinationVanessa Venturi, Katherine Kedzierska, David A Price, et al.
Pageof 50

Showing results (101-110 of 500) with videos related to

Sort By:
Pageof 50
Plos One|February 4, 2012
Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activityNatalija Budimir, Anke Huckriede, Tjarko Meijerhof, et al.
Hormone Research|January 18, 2007
Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short statureMichael B Ranke, Anders Lindberg, David A Price, et al.
Journal of Virology|July 1, 2006
Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivoJason M Brenchley, Laura E Ruff, Joseph P Casazza, et al.
Immunology|January 8, 2009
Tricks with tetramers: how to get the most from multimeric peptide-MHCLinda Wooldridge, Anna Lissina, David K Cole, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2006
Overcoming HERG affinity in the discovery of the CCR5 antagonist maravirocDavid A Price, Duncan Armour, Marcel de Groot, et al.
Current Topics in Medicinal Chemistry|September 11, 2008
Overcoming hERG affinity in the discovery of maraviroc; a CCR5 antagonist for the treatment of HIVDavid A Price, Duncan Armour, Marcel de Groot, et al.
Hormone Research|September 5, 2003
The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiencyEdward O Reiter, Anders Lindberg, Michael B Ranke, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)Michael B Ranke, Anders Lindberg, Christopher T Cowell, et al.
Journal of Leukocyte Biology|September 30, 2008
The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expressionPratip K Chattopadhyay, Michael R Betts, David A Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2006
Sharing of T cell receptors in antigen-specific responses is driven by convergent recombinationVanessa Venturi, Katherine Kedzierska, David A Price, et al.
Pageof 50